Stryker Corporation (NYSE:SYK) Shares Acquired by OneAscent Financial Services LLC

OneAscent Financial Services LLC lifted its stake in shares of Stryker Corporation (NYSE:SYK - Free Report) by 108.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,752 shares of the medical technology company's stock after purchasing an additional 1,432 shares during the period. OneAscent Financial Services LLC's holdings in Stryker were worth $1,026,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of SYK. OneAscent Family Office LLC bought a new position in Stryker in the first quarter worth about $712,000. 1ST Source Bank lifted its holdings in Stryker by 2.0% in the first quarter. 1ST Source Bank now owns 5,652 shares of the medical technology company's stock worth $2,104,000 after acquiring an additional 112 shares during the last quarter. Covenant Asset Management LLC lifted its holdings in Stryker by 1.4% in the first quarter. Covenant Asset Management LLC now owns 10,908 shares of the medical technology company's stock worth $4,061,000 after acquiring an additional 151 shares during the last quarter. Copperwynd Financial LLC raised its holdings in shares of Stryker by 3.5% during the first quarter. Copperwynd Financial LLC now owns 2,444 shares of the medical technology company's stock valued at $910,000 after buying an additional 82 shares during the last quarter. Finally, Kestra Private Wealth Services LLC raised its holdings in shares of Stryker by 2.2% during the first quarter. Kestra Private Wealth Services LLC now owns 19,476 shares of the medical technology company's stock valued at $7,250,000 after buying an additional 412 shares during the last quarter. Institutional investors own 77.09% of the company's stock.

Insiders Place Their Bets

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director owned 3,417,326 shares in the company, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 5.20% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on SYK. Wall Street Zen upgraded shares of Stryker from a "hold" rating to a "buy" rating in a research note on Friday. Citigroup restated a "buy" rating and issued a $455.00 price target (up previously from $443.00) on shares of Stryker in a research report on Thursday, May 22nd. BTIG Research restated a "buy" rating on shares of Stryker in a research report on Monday, July 14th. Evercore ISI lifted their price objective on shares of Stryker from $390.00 to $415.00 and gave the stock an "outperform" rating in a research report on Tuesday, July 8th. Finally, Roth Mkm lifted their target price on shares of Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research note on Friday, May 2nd. Four research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $428.55.

Stryker Trading Down 0.5%

NYSE:SYK traded down $1.82 during trading hours on Monday, hitting $387.58. The company had a trading volume of 791,681 shares, compared to its average volume of 1,349,256. Stryker Corporation has a 52 week low of $314.93 and a 52 week high of $406.19. The company has a market capitalization of $147.94 billion, a PE ratio of 31.08, a price-to-earnings-growth ratio of 2.94 and a beta of 0.91. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00. The stock has a 50-day moving average price of $385.67 and a 200 day moving average price of $378.19.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The business had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.68 billion. During the same period in the previous year, the company posted $2.50 EPS. The business's quarterly revenue was up 11.9% compared to the same quarter last year. On average, equities research analysts predict that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be issued a dividend of $0.84 per share. The ex-dividend date is Monday, June 30th. This represents a $3.36 annualized dividend and a yield of 0.87%. Stryker's payout ratio is presently 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.